Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma
Ingrid Quist-Løkken, Toril Holien, Anders Sundan, Felix Hausch et al.
Citations
3 citations
Journal
Haematologica
Topics
Protein Degradation and Inhibitors
Field-Weighted Citation Impact (FWCI)
2.42
article
Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma
Ingrid Quist-Løkken, Toril Holien, Anders Sundan, Felix Hausch, Clara Andersson-Rusch, Tobias S. Slørdahl, Md Abu Hanif, Michael Walz, Mira Tilseth, Johanna Fredrikke Nordstrand Moen, Megan Anne Vik
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
HaematologicaVol. 110(10)
Institutions
Norwegian University of Science and Technology (NO), Technische Universität Darmstadt (DE)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma — Ingrid Quist-Løkken, Toril Holien, et al. · Haematologica (2025) | TGRS Research Map | TGRS